Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...11121314151617181920...
CompanyDrug NameStatusIndication Group
Schering-Plough Sarasar discontinuedAntineoplastic & immunomodulating agents
Schering-Plough Sarasar in Phase IIIAntineoplastic & immunomodulating agents
Debiopharm Sanvar SR Submitted for approval in FranceNervous system
Debiopharm Sanvar IR Approved in USA, MexicoAlimentary tract & metabolism
Novartis Sandostatin LAR Approved in JapanSystemic hormonal preparations
Novartis Sandostatin LAR Submitted for approval in USASensory organs
Indevus Sanctura XR Approved in USAGenito urinary system & sex hormones
Pliva Sanctura Approved in USAGenito urinary system & sex hormones
Axcan Pharma Salofalk Submitted for approval in USAAlimentary tract & metabolism
MGI PHARMA Saforis Submitted for approval in USAAlimentary tract & metabolism
Durect Saber in Phase IINervous system
Takeda Rozerem Approved in USA, submitted for approval in EUNervous system
Takeda Rozerem in Phase IINervous system
Merck ROTATEQ Approved in USAAnti-infectives for systemic use
GlaxoSmithKline Rotarix Approved in EU, USAnti-infectives for systemic use
Argos Therapeutics RNA-loaded autologous dendritic cell vaccine accomplished Phase IIAntineoplastic & immunomodulating agents
DOR BioPharma RiVax accomplished Phase IAlimentary tract & metabolism
Genentech Rituxan Hematology / Oncology FailedAntineoplastic & immunomodulating agents
Biogen Idec Rituxan in Phase IIIAntineoplastic & immunomodulating agents
Biogen Idec Rituxan Approved in USAMusculoskeletal system
...11121314151617181920...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.